USE OF ANTI-FAM19A5 ANTIBODIES FOR TREATING CANCERS

The present disclosure relates to the pharmaceutical use of antagonists (e.g., an antibody or antigen-binding portion thereof) that specifically bind to FAM19A5 to promote a blood vessel normalizationand treat a disease (e.g., cancer) in a subject in need thereof, e.g., by promoting a blood vessel n...

Full description

Saved in:
Bibliographic Details
Main Authors KIM DONG SIK, KWON SOON-GU, SHIM JUWON, LEE JAE-KEUN, KIM BONGCHEOL, KIM TAE WOO, SEONG JAE YOUNG, CHO EUN BEE, KANG SHIN-HYUK
Format Patent
LanguageChinese
English
Published 01.05.2020
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates to the pharmaceutical use of antagonists (e.g., an antibody or antigen-binding portion thereof) that specifically bind to FAM19A5 to promote a blood vessel normalizationand treat a disease (e.g., cancer) in a subject in need thereof, e.g., by promoting a blood vessel normalization. 本公开涉及特异性结合FAM19A5的拮抗剂(例如抗体或其抗原结合部分)促进血管正常化和例如通过促进血管正常化治疗有需要的受试者的疾病(例如癌症)的药学用途。
Bibliography:Application Number: CN201880050025